Business Description
Krynica Vitamin SA
ISIN : PLKRVTM00010
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 0.8 | |||||
Debt-to-EBITDA | 5.38 | |||||
Interest Coverage | 2.03 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.98 | |||||
Beneish M-Score | -3.12 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7 | |||||
3-Year EBITDA Growth Rate | -47.2 | |||||
3-Year EPS without NRI Growth Rate | -55.8 | |||||
3-Year FCF Growth Rate | -42.6 | |||||
3-Year Book Growth Rate | 0.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.62 | |||||
9-Day RSI | 61.46 | |||||
14-Day RSI | 58.4 | |||||
6-1 Month Momentum % | -20.51 | |||||
12-1 Month Momentum % | -15.56 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.79 | |||||
Quick Ratio | 0.44 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 47.85 | |||||
Days Sales Outstanding | 50.23 | |||||
Days Payable | 78.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.67 | |||||
Dividend Payout Ratio | 3.85 | |||||
3-Year Dividend Growth Rate | -55.3 | |||||
Forward Dividend Yield % | 1.67 | |||||
5-Year Yield-on-Cost % | 1.67 | |||||
Shareholder Yield % | 5.59 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 14.41 | |||||
Operating Margin % | 2.4 | |||||
Net Margin % | -1.86 | |||||
FCF Margin % | 3.07 | |||||
ROE % | -7.45 | |||||
ROA % | -2.88 | |||||
ROIC % | 4.56 | |||||
ROC (Joel Greenblatt) % | -1.74 | |||||
ROCE % | -2.17 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 229.81 | |||||
Shiller PE Ratio | 9.82 | |||||
Price-to-Owner-Earnings | 29.58 | |||||
PS Ratio | 0.41 | |||||
PB Ratio | 1.79 | |||||
Price-to-Tangible-Book | 1.84 | |||||
Price-to-Free-Cash-Flow | 13.24 | |||||
Price-to-Operating-Cash-Flow | 6.79 | |||||
EV-to-EBIT | -84.12 | |||||
EV-to-EBITDA | 17.19 | |||||
EV-to-Revenue | 0.59 | |||||
EV-to-FCF | 19.14 | |||||
Price-to-Projected-FCF | 1.05 | |||||
Price-to-Peter-Lynch-Fair-Value | 44.26 | |||||
Price-to-Graham-Number | 4.33 | |||||
Earnings Yield (Greenblatt) % | -1.19 | |||||
FCF Yield % | 7.54 | |||||
Forward Rate of Return (Yacktman) % | 11.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Krynica Vitamin SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | 359.23 | ||
EPS (TTM) (zł) | -0.811 | ||
Beta | 0.12 | ||
Volatility % | 27.25 | ||
14-Day RSI | 58.4 | ||
14-Day ATR (zł) | 0.431997 | ||
20-Day SMA (zł) | 11.655 | ||
12-1 Month Momentum % | -15.56 | ||
52-Week Range (zł) | 9.74 - 14.75 | ||
Shares Outstanding (Mil) | 12.25 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Krynica Vitamin SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Krynica Vitamin SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Krynica Vitamin SA Frequently Asked Questions
What is Krynica Vitamin SA(WAR:KVT)'s stock price today?
When is next earnings date of Krynica Vitamin SA(WAR:KVT)?
Does Krynica Vitamin SA(WAR:KVT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |